Streptococcinum Homeopathic Drug Recalled Due to Manufacturing Deviations
Washington Homeopathic Products is voluntarily recalling Streptococcinum homeopathic drug in multiple potencies due to manufacturing practice deviations. No illnesses have been reported.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a FDA Class II voluntary recall with no reported illnesses or injuries. The recall is due to manufacturing process deviations and was initiated by the company, meeting the criteria for a voluntary precautionary recall.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Streptococcinum homeopathic drug in potencies 8C, 9C, 30C, and 200C supplied in 5 glass amber bottles. Affected lot numbers are 21902 and 21927.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations. The FDA classified this as a Class II recall on June 10, 2022. The company voluntarily initiated the recall on May 13, 2022.
The product was distributed nationwide throughout the United States. The recall was terminated on May 25, 2023.
The recalled product
- Product
- Streptococcinum, Potency: 8C, 9C, 30C, 200C, Liquid Pellets, Rx only, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- Affected units
- 5
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 21902
- 21927
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 17 recalled by Washington Homeopathic Products, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Washington Homeopathic Products, Inc.
See all →- LowHomeopathic Kit Recalled for Label Mix-up Between Products
FDA (Drugs) · 2024-07-31
- ModerateHomeopathic Drug Recall: Vaccinotoxinum Products Due to Manufacturing Violations
FDA (Drugs) · 2022-06-22
- ModerateDrug recall: Tuberculinum Bovinum due to manufacturing practice deviations
FDA (Drugs) · 2022-06-22
- ModeratePyrogenium Homeopathic Remedy Recalled for Manufacturing Process Violations
FDA (Drugs) · 2022-06-22
- ModerateHomeopathic Colibacillinum Drug Recall Due to Manufacturing Deviations
FDA (Drugs) · 2022-06-22
Same hazard · manufacturing deviation
See all →- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateSynjardy XR Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
Similar recalls
- ModerateWashington Homeopathic Recalls Natrum Sulphuricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- HighWashington Homeopathic Products Recalls Silicea 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Recalls Natrum Muriaticum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Products Recalls Kali Sulphuricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Recalls Ferrum Phosphoricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Products Recalls Natrum Phosphoricum 6X Tablets
FDA (Drugs) · 2019-11-27